Overview
Jianping Xiong practices practicing medicine in Tokyo, Japan.
Xiong is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Nearsightedness, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Alport Syndrome.
They are actively involved in clinical research, co-authoring 19 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jianping Xiong
Is Jianping Xiong a top-rated expert for Nearsightedness?
MediFind is an objective health platform that identifies experts based on real-world data. Jianping Xiong is classified as an Advanced expert for Nearsightedness, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jianping Xiong participate in research or clinical trials?
Yes. Jianping Xiong has published 19 articles and abstracts on conditions like Nearsightedness. You can view a list of Jianping Xiong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- NearsightednessXiong isAdvanced. Learn about Nearsightedness.
- Experienced
- Age-Related Macular Degeneration (ARMD)
- Alport SyndromeXiong isExperienced. Learn about Alport Syndrome.
- Late-Onset Retinal Degeneration